FERRING Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FERRING, and when can generic versions of FERRING drugs launch?
FERRING has seventeen approved drugs.
There are twenty US patents protecting FERRING drugs.
There are two hundred and seventy-seven patent family members on FERRING drugs in forty countries and twenty-two supplementary protection certificates in ten countries.
Summary for FERRING
International Patents: | 277 |
US Patents: | 20 |
Tradenames: | 17 |
Ingredients: | 8 |
NDAs: | 17 |
Patent Litigation for FERRING: | See patent lawsuits for FERRING |
Drugs and US Patents for FERRING
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | 9,579,359 | ⤷ Subscribe | ⤷ Subscribe | ||||
Ferring Pharms Inc | DDAVP (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 017922-003 | Aug 7, 1996 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-001 | Jun 21, 2018 | DISCN | Yes | No | 7,560,429 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | 10,695,398 | ⤷ Subscribe | ⤷ Subscribe | ||||
Ferring Pharms Inc | STIMATE | desmopressin acetate | SPRAY, METERED;NASAL | 020355-001 | Mar 7, 1994 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | DISCN | Yes | No | 7,560,429 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FERRING
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | 8,802,624 | ⤷ Subscribe |
Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-001 | Jun 21, 2018 | 9,504,647 | ⤷ Subscribe |
Ferring Pharms Inc | DDAVP | desmopressin acetate | SPRAY, METERED;NASAL | 017922-002 | Feb 6, 1989 | 5,763,407 | ⤷ Subscribe |
Ferring Pharms Inc | CERVIDIL | dinoprostone | INSERT, EXTENDED RELEASE;VAGINAL | 020411-001 | Mar 30, 1995 | 5,269,321 | ⤷ Subscribe |
Ferring Pharms Inc | DDAVP | desmopressin acetate | TABLET;ORAL | 019955-002 | Sep 6, 1995 | 5,763,407 | ⤷ Subscribe |
Ferring Pharms Inc | DDAVP (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 017922-003 | Aug 7, 1996 | 5,500,413 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for FERRING drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Oral Solution | 10 mg, 3.5 g, and12 g | ➤ Subscribe | 2019-02-11 |
➤ Subscribe | Oral Solution | 10 mg, 3.5 g, and 12 g | ➤ Subscribe | 2014-05-21 |
International Patents for FERRING Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Germany | 60307082 | ⤷ Subscribe |
China | 110898207 | ⤷ Subscribe |
Portugal | 3225250 | ⤷ Subscribe |
Eurasian Patent Organization | 200901074 | ⤷ Subscribe |
China | 101820859 | ⤷ Subscribe |
Spain | 2596435 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for FERRING Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1003774 | SPC/GB09/028 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: DEGARELIX OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT SUCH AS THE ACETATE; REGISTERED: UK EU/1/08/504/001 20090217; UK EU/1/08/504/002 20090217 |
2712622 | C02712622/01 | Switzerland | ⤷ Subscribe | PRODUCT NAME: DESMOPRESSIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66379 16.03.2018 |
1003774 | 91585 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: DEGARELIX, EVENTUELLEMENT UN SEL PHARMACEUTIQUEMENT ACCEPTABE, TEL QUE L'ACETATE (FIRMAGON); REG. DATE: 20090217 |
2782584 | LUC00245 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (Y COMPRIS SOUS FORME HEMIHYDRATEE), ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210701 |
3225249 | 2019C/520 | Belgium | ⤷ Subscribe | PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513 |
1003774 | PA2009005 | Lithuania | ⤷ Subscribe | PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.